Article Summary
李志杰 张卓然 韩世愈 史文华 林楠.趋化因子受体CCR3 在上皮性卵巢癌中的表达及临床意义[J].现代生物医学进展英文版,2014,14(23):4494-4496.
趋化因子受体CCR3 在上皮性卵巢癌中的表达及临床意义
Expression and Clinical Significance of CCR3 in Human Epithelial Ovarian Cancer
  
DOI:
中文关键词: 卵巢癌  趋化因子受体  CCR3  逆转录聚合酶反应
英文关键词: Ovarian cancer  Chemokine receptor  CCR3  Reverse transcriptase polymerase chain reaction
基金项目:黑龙江省卫生厅科研项目(2010132)
Author NameAffiliation
LI Zhi-jie, ZHANG Zhuo-ran,HAN Shi-yu, SHI Wen-hua, LIN Nan 哈尔滨医科大学附属第四医院妇产科
哈尔滨医科大学附属第四医院药剂科 
Hits: 831
Download times: 904
中文摘要:
      目的:探讨趋化因子受体CCR3 在上皮性卵巢癌组织中的表达情况,以及其与卵巢癌临床病理特征的关系。方法:收集上皮 性卵巢癌组织、良性上皮性卵巢肿瘤组织以及正常卵巢组织标本各30 例,采用多聚腺苷酸加尾实时荧光定量反转录聚合酶链反 应[poly(A)-RT-qPCR]检测其CCR3 的表达,并分析上皮性卵巢癌组织中CCR3 的表达与患者临床病理特征之间的关系。结果:上 皮性卵巢癌组织中CCR3 的表达显著高于良性卵巢肿瘤组和正常卵巢组,差异有统计学意义(P<0.05);且上皮性卵巢癌组织中 CCR3的表达与患者的分期、组织分级及淋巴结转移均显著相关(P<0.05)。结论:CCR3 在上皮性卵巢癌组织中呈高表达,且在上 皮性卵巢癌的发生和发展过程中均起着十分重要的作用。
英文摘要:
      Objective:To investigate the expression of chemokine receptor CCR3 in epithelial ovarian carcinoma, and the relationship with the clinicopathological characteristics.Methods:Tissue samples of epithelial ovarian cancer (30 cases), benign ovarian tumor(30 cases) and normal ovarian(30 cases) were collected, the polyadenylation real-time fluorescent quantitative reverse transcription polymerase chain reaction (A [poly) -RT-qPCR] were used to detect the expression of CCR3, and analyze the correlation of CCR3 expression with the clinicopathological characteristics.Results:The expression of CCR3 in ovarian cancer group was significantly higher than those in the benign ovarian tumors and normal ovarian group (P<0.05), which was also markedly correlated with the staging, histological grade and lymph node metastasis of epithelial ovarian carcinoma (P<0.05).Conclusion:The upregulation of CCR3 expression played an important role in the development of epithelial ovarian carcinoma.
View Full Text   View/Add Comment  Download reader
Close